Huiyu Pharmaceutical: Wang Xiaopeng plans to reduce his holdings by 3% in 3 months.

Huiyu Pharmaceuticals announced that shareholder Ms. Wang Xiaopeng holds 17.0376 million shares, accounting for 4.022% of the total share capital of the company; due to personal fund needs, she plans to reduce her holdings through concentrated bidding from October 24, 2025 to January 21, 2026. The number of shares will not exceed 4.236 million shares, and the number of shares reduced through block trading will not exceed 8.472 million shares, with a total reduction of not more than 12.708 million shares, and the reduction ratio will not exceed 3%.